Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy

Table 1

Characteristics of the study group at baseline.

	Study group (n = 30)
Age (years), mean ± SD	65.4 ± 6.5
Gender, n (%)
Male	14 (46.7)
Female	16 (53.3)
BCVA (logMAR), median (1st quartile–3rd quartile)	0.50 (0.50–0.60)
Diabetes duration (years), mean ± SD	16.4 ± 5.2
HbA1c (%), mean ± SD	8.18 ± 0.72
Insulin-dependent (yes/no)	25/5
Phakic eye, n	27
CMT (μm), median (1st quartile–3rd quartile)	452 (352.0–514.0)

BCVA: best-corrected visual acuity; CMT: central macular thickness.